GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (OTCPK:NBHGF) » Definitions » Total Inventories

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Total Inventories : $35.6 Mil (As of Dec. 2013)


View and export this data going back to . Start your Free Trial

What is Nobel Biocare Holding AG Total Inventories?

Nobel Biocare Holding AG's total inventories for the quarter that ended in Dec. 2013 was $35.6 Mil. Nobel Biocare Holding AG's average total inventories from the quarter that ended in Dec. 2012 to the quarter that ended in Dec. 2013 was $31.2 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Nobel Biocare Holding AG's Net-Net Working Capital per share for the quarter that ended in Dec. 2013 was $-0.87.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Nobel Biocare Holding AG's Days Inventory for the six months ended in Dec. 2013 was 30.48.

Inventory Turnover measures how fast the company turns over its inventory within a year. Nobel Biocare Holding AG's Inventory Turnover for the quarter that ended in Dec. 2013 was 5.99.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Nobel Biocare Holding AG's Inventory-to-Revenue for the quarter that ended in Dec. 2013 was 0.04.


Nobel Biocare Holding AG Total Inventories Historical Data

The historical data trend for Nobel Biocare Holding AG's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nobel Biocare Holding AG Total Inventories Chart

Nobel Biocare Holding AG Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.86 30.95 31.51 26.82 35.63

Nobel Biocare Holding AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.86 30.95 31.51 26.82 35.63

Nobel Biocare Holding AG Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Nobel Biocare Holding AG  (OTCPK:NBHGF) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Nobel Biocare Holding AG's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2013 is

Net-Net Working Capital Per Share (Q: Dec. 2013 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(252.079+0.75 * 0+0.5 * 35.629-376.462
-0-0)/122.627
=-0.87

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Nobel Biocare Holding AG's Days Inventory for the six months ended in Dec. 2013 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2013 )/Cost of Goods Sold (Q: Dec. 2013 )*Days in Period
=31.222/186.945*365 / 2
=30.48

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Nobel Biocare Holding AG's Inventory Turnover for the quarter that ended in Dec. 2013 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2013 ) / Average Total Inventories (Q: Dec. 2013 )
=186.945 / 31.222
=5.99

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Nobel Biocare Holding AG's Inventory to Revenue for the quarter that ended in Dec. 2013 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2013 ) / Revenue (Q: Dec. 2013 )
=31.222 / 776.422
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Nobel Biocare Holding AG Total Inventories Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description

Traded in Other Exchanges
N/A
Address
Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Headlines